Diamyd Medicals fas III-studie publicerad i New England Journal of Medicine
February 02, 2012 02:30 ET
|
Mertiva
Diamyd Medicals fas III-studie publicerad i New England Journal of Medicine
En artikel med resultaten från Diamyd Medicals europeiska fas III-studie med den
antigenbaserade diabetesterapin Diamyd®...
Diamyd Medical's Phase III study published in the New England Journal of Medicine
February 02, 2012 02:30 ET
|
Mertiva
Diamyd Medical's Phase III study published in the New England Journal of
Medicine
An article with the results of Diamyd Medical's European Phase III study of the
antigen-based diabetes therapy...
Delårsrapport I 11/12
January 25, 2012 02:30 ET
|
Mertiva
Delårsrapport I 11/12
Delårsrapport Diamyd Medical AB (publ), räkenskapsåret 2011/2012
(www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY)
Perioden 1 september 2011 – 30 november...
Quarterly Report I 11/12
January 25, 2012 02:30 ET
|
Mertiva
Quarterly Report I 11/12
Quarterly Report Diamyd Medical AB (publ), fiscal year 2011/2012
(www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY)
Reporting period September 1, 2011 – November...
Prevention study with Diamyd´s diabetes vaccine fully recruited
January 09, 2012 02:30 ET
|
Mertiva
Prevention study with Diamyd´s diabetes vaccine fully recruited
A total of 50 children aged four and older with a high risk of developing type 1
diabetes have been enrolled in a researcher-initiated...
Preventionsstudie med Diamyds diabetesvaccin fullrekryterad
January 09, 2012 02:30 ET
|
Mertiva
Preventionsstudie med Diamyds diabetesvaccin fullrekryterad
Totalt 50 barn från fyra års ålder med hög risk att utveckla typ 1-diabetes har
inkluderats i en forskarinitierad fas II-studie,...
Annual Report 10/11
December 08, 2011 12:42 ET
|
Mertiva
Annual Report 10/11
Q1
• Results from Phase I study in cancer pain shows promising safety data and
relief of chronic pain
Q2
• Recruitment for US Phase III study in type 1 diabetes is completed
•...
Bulletin from Annual General Meeting: Diamyd Medical towards new goals
December 07, 2011 13:18 ET
|
Mertiva
Bulletin from Annual General Meeting: Diamyd Medical towards new goals
At Diamyd Medical’s Annual General Meeting on December 7, Peter Zerhouni,
President and CEO, commented that the past year had...
Kommuniké från bolagsstämma: Diamyd Medical mot nya mål
December 07, 2011 13:18 ET
|
Mertiva
Kommuniké från bolagsstämma: Diamyd Medical mot nya mål
Vid Diamyd Medicals ordinarie bolagsstämma den 7 december meddelade vd Peter
Zerhouni att det gångna året har varit händelserikt och...
University of Florida Research Foundation och Diamyd Medical når förlikning i tvist
November 17, 2011 02:30 ET
|
Mertiva
University of Florida Research Foundation och Diamyd Medical når
förlikning i tvist
University of Florida Research Foundation, Incorporated (”UFRF”) och
Diamyd Medical AB meddelar idag gemensamt att...